Location History:
- Oxfordshire, GB (2016 - 2018)
- Abingdon, GB (2019 - 2023)
Company Filing History:
Years Active: 2016-2025
Title: The Innovative Contributions of Naomi Went in the Field of ENaC Inhibitors
Introduction: Naomi Went, an accomplished inventor based in Abingdon, GB, has made significant strides in the development of novel therapeutic compounds. With a remarkable portfolio of seven patents, her work primarily focuses on inhibitors of the epithelial sodium channel (ENaC), which are pivotal in treating various respiratory, skin, and ocular conditions.
Latest Patents: Naomi's recent patents showcase her dedication to improving health outcomes through innovative chemical compounds. One noteworthy patent involves substituted benzodiazoliums, detailed as compounds of general formula (I), which serve as ENaC inhibitors. These compounds are instrumental in the treatment or prevention of respiratory diseases, skin conditions, and ocular conditions. Another significant contribution from Naomi includes bis(pentahydroxyhexyl)amino substituted 2-{[(3-amino-pyrazin-2-yl)formamido]methyl}-1H-1,3-benzodiazol-3-ium derivatives. This invention also acts as ENaC inhibitors and is intended for treating various respiratory diseases such as cystic fibrosis and chronic obstructive pulmonary disease (COPD), in addition to skin conditions like psoriasis and ocular conditions like dry eye disease.
Career Highlights: Throughout her career, Naomi has demonstrated exceptional expertise in her field, contributing to the development of therapeutic solutions that bridge gaps in current medical treatments. Her innovative approach to pharmaceuticals has set a path for future discoveries, enhancing quality of life for many patients.
Collaborations: Naomi Went has worked alongside esteemed professionals in the industry, including Clive McCarthy and Duncan Alexander Hay. Her tenure at organizations like Enterprise Therapeutics Limited and Orca Pharmaceuticals Limited has further solidified her reputation as a leading figure in pharmaceutical innovation.
Conclusion: Naomi Went’s impressive contributions to the field of science and her focus on ENaC inhibitors underline the importance of innovation in addressing medical challenges. With her extensive patent portfolio and collaborations with notable figures, Naomi has established herself as a significant inventor dedicated to the advancement of healthcare.